Xiao-Yan Chu
Merck & Co.
Inc., Pharmacokinetics Pharmacodynamics and Drug Metabolism
126 East Lincoln Avenue
USA
Name/email consistency: high
- Species differences in drug transporters and implications for translating preclinical findings to humans. Chu, X., Bleasby, K., Evers, R. Expert. Opin. Drug. Metab. Toxicol (2013)
- Metabolism and renal elimination of gaboxadol in humans: role of UDP-glucuronosyltransferases and transporters. Chu, X.Y., Liang, Y., Cai, X., Cuevas-Licea, K., Rippley, R.K., Kassahun, K., Shou, M., Braun, M.P., Doss, G.A., Anari, M.R., Evers, R. Pharm. Res. (2009)
- Transport of the dipeptidyl peptidase-4 inhibitor sitagliptin by human organic anion transporter 3, organic anion transporting polypeptide 4C1, and multidrug resistance P-glycoprotein. Chu, X.Y., Bleasby, K., Yabut, J., Cai, X., Chan, G.H., Hafey, M.J., Xu, S., Bergman, A.J., Braun, M.P., Dean, D.C., Evers, R. J. Pharmacol. Exp. Ther. (2007)
- Characterization of mice lacking the multidrug resistance protein MRP2 (ABCC2). Chu, X.Y., Strauss, J.R., Mariano, M.A., Li, J., Newton, D.J., Cai, X., Wang, R.W., Yabut, J., Hartley, D.P., Evans, D.C., Evers, R. J. Pharmacol. Exp. Ther. (2006)
- Transport of ethinylestradiol glucuronide and ethinylestradiol sulfate by the multidrug resistance proteins MRP1, MRP2, and MRP3. Chu, X.Y., Huskey, S.E., Braun, M.P., Sarkadi, B., Evans, D.C., Evers, R. J. Pharmacol. Exp. Ther. (2004)









